Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics
Additional funding awarded following successful drug candidate nominationUSD 7.3 million to support…
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients
HUNTSVILLE, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE…
IOC Ethics Commission draws lots to determine order of presidential candidate presentations
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing…
IOC Ethics Commission draws lots to determine order of presidential candidate presentations
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing…
IOC Ethics Commission draws lots to determine order of presidential candidate presentations
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing…
IOC Ethics Commission draws lots to determine order of presidential candidate presentations
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing…
IOC Ethics Commission draws lots to determine order of presidential candidate presentations
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing…
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimers Disease
November 20, 2024 07:00 ET | Source: Voyager Therapeutics, Inc. - Candidate…
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on…